Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
JAZZJazz Pharmaceuticals(JAZZ) Prnewswire·2024-02-21 20:45

Jazz Pharmaceuticals任命Philip Johnson为执行副总裁和首席财务官 - Jazz Pharmaceuticals宣布任命Philip Johnson为执行副总裁和首席财务官[1] - Philip Johnson在Eli Lilly and Company担任集团副总裁财务职务超过35年[2] - Jazz Pharmaceuticals董事长兼首席执行官Bruce Cozadd表示，Philip Johnson的任命是为了继续执行公司增长和多元化战略[3]